In pursuit of optimal outcomes: A framework for quality standards in immune effector cell therapy Editorial
| Authors: | Dandoy, C. E.; Adams, J.; Artz, A.; Bredeson, C.; Dahi, P. B.; Dodd, T.; Jaglowski, S.; Lehmann, L.; LeMaistre, C. F.; Mian, A.; Neal, A.; Page, K.; Rizzo, J. D.; Rotz, S.; Sorror, M.; Steinberg, A.; Viswabandya, A.; Howard, D. S.; For the Committee on Quality Outcomes of the American Society of Transplant and Cellular Therapy |
| Title: | In pursuit of optimal outcomes: A framework for quality standards in immune effector cell therapy |
| Abstract: | Immune effector cell (IEC) therapy represents a transformative advancement in oncology, leveraging the immune system to combat various malignancies. This article outlines a comprehensive framework for establishing and maintaining quality standards in IEC therapy amidst rapid scientific and clinical advancements. We emphasize the integration of structured process measures, robust quality assurance, and meticulous outcome evaluation to ensure treatment efficacy and safety. Key components include multidisciplinary expertise, stringent accreditation protocols, and advanced data management systems, which facilitate standardized reporting and continual innovation. The collaborative effort among stakeholders—ranging from patients and healthcare providers to regulatory bodies—is crucial in delivering high-quality IEC therapies. This framework aims to enhance patient outcomes and cement the role of IEC therapy as a cornerstone of modern oncology, promoting continuous improvement and adherence to high standards across the therapeutic spectrum. © 2024 The American Society for Transplantation and Cellular Therapy |
| Keywords: | treatment outcome; outcome assessment; neoplasm; neoplasms; quality control; cancer immunotherapy; editorial; oncology; information processing; health care quality; health insurance; health program; legal aspect; standardization; patient care; immunology; immunotherapy; total quality management; quality assurance, health care; processing; patient safety; health care personnel; accreditation; therapy effect; biological therapy; health care delivery; therapy; professional standard; quality improvement; drug industry; procedures; capacity building; family attitude; materials handling; employer; cellular immunotherapy; humans; human; cell- and tissue-based therapy; data integration; multidisciplinary team; patient engagement; collaborative care team; patient volume; immune effector cell therapy; research infrastructure; stakeholder engagement; transplant and cellular therapy; patient safety, quality of care; service infrastructure |
| Journal Title: | Transplantation and Cellular Therapy |
| Volume: | 30 |
| Issue: | 10 |
| ISSN: | 2666-6375 |
| Publisher: | Elsevier Inc. |
| Date Published: | 2024-10-01 |
| Start Page: | 942 |
| End Page: | 954 |
| Language: | English |
| DOI: | 10.1016/j.jtct.2024.07.011 |
| PUBMED: | 39067790 |
| PROVIDER: | scopus |
| DOI/URL: | |
| Notes: | Editorial -- Source: Scopus |
